Skip to main content
Premium Trial:

Request an Annual Quote

Howard Hughes Slashes Spending; Lab Budgets to Decline 20 Percent

NEW YORK, Nov. 18 - The Howard Hughes Medical Institute, one of the country's major non-governmental funders of biomedical research, said last week that the weak economy has forced it to cut grants, administrative expenses, and research budgets.


The nonprofit institute spent about $665 million underwriting science education and biomedical research in 2001. But as national and global economies slowed, the HHMI endowment has dwindled from a peak of $13.4 billion in 2000 to roughly $10 billion today.


As a result, the institute has cut staff, instituted a hiring freeze, and reduced administrative costs by about $3.5 million. HHMI has eliminated its Research Resources program, which doled out about $22 million a year to help medical schools improve their labs, and its science education grants program is "under review." This program, funded at $114 million last year, subsidizes education costs for foreign researchers, undergrad, and graduate science students.


HHMI investigators will see their budgets reduced by up to 10 percent a year for the next two years.


The Howard Hughes Medical Institute chooses elite investigators in labs across the country to support them with generous grants for a minimum of five to seven years. Technically, they are employees of the institute, but most investigators remain onsite at their home universities. At the end of 2001, the institute employed 337 investigators at 70 sites.


Current HHMI investigators include Massachusetts Institute of Technology's H. Robert Horvitz, Stanford's Patrick Brown, and University of California at Santa Cruz' David Haussler.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.